Autism Researchers Propose Sorting Variation by Developmental Timing | Executive Function News
Independent Journalism on Executive Function and Neuroscience

Executive Function News

Reporting on the Science and Practice of Executive Function
Neuroscience

Autism Researchers Propose Sorting Variation by Developmental Timing

A Perspective published November 18 in Nature Mental Health argues that when autistic traits emerge, and when a diagnosis follows, may mark different developmental pathways with different support needs. It proposes a research framework. It does not report a treatment trial.

Three pairs of shoes in different sizes lined up on a wooden floor against a whitewashed wood wall: olive canvas sneakers, light blue fleece-lined clogs, and small brown toddler boots, illustrating different stages of development.
Development unfolds in stages, and a new Perspective in Nature Mental Health proposes using developmental trajectories, including the age at which autistic traits emerge and the age at diagnosis, to organize variation in autism. Photo: Executive Function News.

Autism does not follow one developmental course. Some children show clear differences in social communication before their second birthday. Others are evaluated carefully in preschool, do not meet criteria, and are diagnosed years later. A Perspective published November 18, 2026 in Nature Mental Health argues that this difference in timing is more than a scheduling detail. The authors propose that when autistic traits emerge, and when a diagnosis follows, may mark different developmental pathways with different biology and different support needs.

The paper, titled “Elucidating the heterogeneity in autism through developmental trajectories,” was written by Mark H. Johnson of the University of Cambridge and Birkbeck, University of London; Tony Charman of King’s College London; Varun Warrier of the University of Cambridge; and Emily J. H. Jones of Birkbeck and King’s College London. It is a Perspective, which means it argues for a way of organizing existing evidence. It does not report new trial data, and it does not test any treatment or support strategy.

That distinction shapes how the paper should be read. The authors are proposing a research framework. Whether that framework holds up depends on studies that have not yet been done. What can be examined today is the published evidence the framework rests on, and that evidence is substantial enough to be worth understanding in detail.

At a Glance
  • The Perspective appeared in Nature Mental Health on November 18, 2026. It proposes a framework and reports no treatment trial.
  • Its organizing concept is chronogeneity: variation in how a condition develops over time. The term was coined in a 2017 editorial by Georgiades, Bishop, and Frazier.
  • The authors draw on four lines of evidence: traits detected after early childhood, early brain predictors, genetic profiles, and co-occurring mental health conditions.
  • A 2025 study in Nature estimated that common genetic variants account for about 11 percent of the variation in age at autism diagnosis.
  • In a UK birth cohort of 430 autistic children, those diagnosed between ages 8 and 14 had fewer reported difficulties at age 5 than earlier-diagnosed children, and more by age 14.
  • In U.S. surveillance data for 2022, the median age of earliest known autism diagnosis among 8-year-olds was 47 months.

What the Paper Proposes

Researchers have long described autism as heterogeneous. Autistic people differ from one another in language, cognitive ability, sensory experience, co-occurring conditions, and daily support needs. That variation is well documented and poorly explained, and it complicates nearly every research question in the field. A study that averages across very different people can easily find nothing, even when something real is there for some of them.

The Perspective suggests one way to bring order to the variation: sort by developmental trajectory. Under this approach, the age at which autistic traits emerge and the age at which a diagnosis is made become variables that researchers use to group participants, on the theory that people who share a developmental course may also share underlying causes and later needs.

According to the published abstract, the authors review four lines of emerging evidence, discuss how developmental trajectories could be used to stratify autism, describe ways to test the framework further, and consider its clinical implications.

A Term With a History

The word the authors use for this idea, chronogeneity, is not new. Stelios Georgiades of McMaster University, Somer L. Bishop, and Thomas Frazier introduced it in a 2017 editorial in the Journal of Child Psychology and Psychiatry. They coined it to describe autism heterogeneity in relation to the dimension of time.

Their argument was that variation in how autistic children change over time should not be treated as statistical noise around a group average. They described it as informative variance that could support more precise and more adaptive models of care for children and youth. The 2026 Perspective takes that concept and connects it to a body of genetic, neural, and clinical evidence that has grown considerably in the years since.

Strand One: Traits That Are Detected Later

The first line of evidence comes from prospective family-history studies. These studies enroll infants who have an older autistic sibling and follow them from the first months of life, with repeated expert assessments. Because the children are watched so closely, the studies can separate two situations that look identical in ordinary clinical records: a child whose early signs were missed, and a child whose signs were not yet detectable.

A 2018 study led by Sally Ozonoff, published in the Journal of the American Academy of Child and Adolescent Psychiatry, pooled data from three research teams in the United States, Canada, and the United Kingdom. Tony Charman, a co-author of the new Perspective, was among its authors. The study identified 14 children who had been classified as not having autism at age 3 and who met criteria at a school-age follow-up conducted between ages 5 and 9.

At age 3, these children generally scored between the typically developing group and the group already diagnosed with autism. They were not a uniform group. Seven of the 14 showed significant increases in observed autism features between age 3 and school age, while the other seven remained stable. The authors concluded that some children present with subtle early features or a prolonged course of symptom development, and they called for screening and surveillance to continue beyond 36 months.

The study’s limits are plain. Fourteen children is a small group. All came from families with an autistic older sibling, so the findings may not generalize to children without that family history. Parents with ongoing concerns may also have been more likely to return for follow-up, which means the study cannot say how common later diagnosis is.

Population data show that diagnosis after the preschool years is common in ordinary practice. The CDC’s Autism and Developmental Disabilities Monitoring Network reported that among children aged 8 years in 2022, the median age of earliest known autism diagnosis was 47 months, and that it ranged from 36 months at the California site to 69.5 months at the Texas (Laredo) site. Those figures reflect access to evaluation as well as development, which is one reason researchers have turned to closely monitored cohorts to separate the two.

Strand Two: Early Brain Measures

The second line of evidence concerns the infant brain. The Perspective reports that a later age at diagnosis is linked to different early brain predictors than an earlier diagnosis, which the authors interpret as a sign of neurodevelopmental differences between the groups. The paper’s first figure illustrates the point with infant EEG responses to faces and to noise, recorded in infant siblings who were then followed into childhood.

If that pattern holds, it matters for a simple reason. A child diagnosed at age 9 would not be a child diagnosed at age 3 whose signs were overlooked. The early brain measures themselves would differ.

Strand Three: Genetics

The third line of evidence is genetic, and it rests heavily on a study published in Nature in October 2025. Xinhe Zhang was the lead author and Varun Warrier, a co-author of the new Perspective, was the senior author.

Using longitudinal data from four independent birth cohorts, that study found two different socioemotional and behavioral trajectories associated with age at diagnosis. Children diagnosed earlier, typically before age six, were more likely to show difficulties such as social interaction problems from early childhood. People diagnosed later were more likely to develop social and behavioral difficulties in adolescence.

The genetic analysis drew on data from more than 45,000 autistic people in cohorts across Europe and the United States, according to the University of Cambridge’s summary of the work. Common genetic variants accounted for approximately 11 percent of the variance in age at diagnosis. The researchers described two genetic factors with only modest overlap. One was associated with earlier diagnosis and was only moderately genetically correlated with ADHD and mental health conditions. The other was associated with later diagnosis and had moderate to high positive genetic correlations with ADHD and mental health conditions. On average, the genetic profile of later-diagnosed autism sat closer to that of ADHD, depression, and PTSD than to the profile of autism diagnosed in early childhood.

The researchers attached clear cautions. Zhang noted that the differences are averages along a gradient, and that “earlier” and “later” diagnosis are not valid diagnostic terms. The team also said that a lack of support in early childhood likely contributes to the higher mental health risk seen in the later-diagnosed group, for example through greater vulnerability to bullying before diagnosis. The study did not establish that the genetic overlap causes those mental health conditions.

The new Perspective adds that rare-variant profiles, as well as polygenic ones, differ by developmental pattern.

Strand Four: Mental Health

The fourth line of evidence is that co-occurring mental health profiles vary with age at diagnosis. A 2022 study by Will Mandy of University College London and colleagues, published in the Journal of Child Psychology and Psychiatry, shows what that looks like across childhood.

The researchers used the Millennium Cohort Study, a population-based UK birth cohort, and identified 430 children whose parents reported an autism diagnosis. Of those, 146 were diagnosed by age 7 and 284 were diagnosed between ages 8 and 14. Parents completed the Strengths and Difficulties Questionnaire when the children were 3, 5, 7, 11, and 14.

At age 5, the late-diagnosed children had fewer emotional, conduct, hyperactivity, and peer problems than the earlier-diagnosed children. Their difficulties then increased faster in all four areas. By age 14, the late-diagnosed group had higher overall levels of difficulties, and their peer problems had risen into the abnormal range. The pattern remained after the researchers adjusted for ADHD status, cognitive ability, sex, and maternal characteristics.

The late-diagnosed children were not free of difficulty before their diagnosis. At age 7, about half scored in the borderline or abnormal range for conduct problems, hyperactivity, and peer problems. The study relied on parent report, did not capture the exact timing of each diagnosis, and was descriptive. The authors stated that it cannot establish whether earlier diagnosis would have changed the later course.

A profile documented at age four or age fourteen describes that moment. The evidence on developmental timing suggests it should not be read as a fixed description of the person.

Where Executive Function Fits

The Perspective is about autism as a whole, and its abstract does not single out executive function. Two longitudinal studies published in 2026, which are separate from the Perspective, show that the same question of timing applies to executive function in autistic children and young adults.

A study from the Infant Brain Imaging Study network, led by Tanya St John and published in the Journal of Neurodevelopmental Disorders in March 2026, followed 83 autistic children and 235 non-autistic children who each had an older autistic sibling, along with 132 children who did not. Executive function was assessed at 12 and 24 months and again at school age, between 5 and 14 years. The groups did not differ at 12 months. At 24 months, both groups of children with an autistic sibling scored lower than the comparison group. At school age, the autistic children scored lower than both other groups on every executive function measure. The authors concluded that executive function supports starting in toddlerhood may be useful for children in this population who show emerging difficulties.

A second study, from Lauren Kenworthy’s team at Children’s National Hospital and published in the Journal of Child Psychology and Psychiatry, followed 313 autistic participants across 941 observations between ages 2 and 25. Parent-reported executive function challenges in flexibility, working memory, and inhibition persisted across that entire age range, regardless of cognitive ability or parent education. Over the same period, aggression symptoms declined with age, depression symptoms increased, and autistic females showed a distinct rise in anxiety during adolescence. Flexibility challenges predicted anxiety, depression, and aggression. The authors described executive function as a persistent predictor that can still be changed, which makes it an intervention target.

Read together, the two studies describe executive function differences that emerge over time and whose consequences shift with age. A difference that is not measurable at 12 months is measurable at 24. A challenge that is linked with aggression in childhood is linked with depression later.

What the Paper Does Not Show

Several limits apply to the Perspective and to the evidence behind it.

The paper does not establish subtypes of autism. It proposes developmental trajectory as a stratification factor for research and care, and the authors themselves describe the need to test the framework further.

Age at diagnosis is an imperfect stand-in for age at emergence. When a child is diagnosed depends on access to evaluation, on the adults who notice and refer, and on how a child’s traits are interpreted. The Cambridge researchers said that the timing of diagnosis reflects more than healthcare access or awareness, and also that those factors matter. Any research program built on timing has to separate the two.

Group averages do not describe individuals. The genetic findings are averages along a gradient with overlap between groups, and common variants explained roughly a tenth of the variation in age at diagnosis. Nothing in this research allows a clinician, teacher, coach, or parent to infer a person’s biology or future from the age at which they were diagnosed.

The full text of the Perspective is available by subscription. This report is based on the published abstract, the article’s summary of its first figure, and the earlier studies named above.

What It Means for Assessment and Support

The practical reading is narrower than the research agenda, and it does not depend on the framework being confirmed. The studies behind the Perspective already show that an assessment captures one point in time.

In the sibling research, children who did not meet criteria at age 3 met them by school age, and half of that group showed measurable increases in autism features in between. In the UK cohort, children who looked less affected at age 5 were more affected by age 14. In the executive function research, the challenges persisted from early childhood to age 25 while the mental health picture around them changed.

For clinicians, educators, and coaches, the consistent implication is that a support plan built on an early profile needs to be revisited. Demands change as a person moves through school transitions, adolescence, and entry into work. A plan written for the demands of second grade was not written for the demands of ninth grade, and the evidence gives no reason to assume the person’s profile stayed the same in between. Ozonoff and colleagues made a version of this point for surveillance, recommending continued evaluation of children with atypical early development or a strong family history. The mental health findings make it for later-identified adolescents, who in the UK cohort carried high levels of difficulty before anyone named autism.

What Comes Next

The Perspective sets out a program of work. Testing it will require studies that follow people over long periods, that measure when traits emerge and not only when a diagnosis is recorded, and that can separate developmental timing from differences in access to evaluation.

If the framework holds, age of emergence could become a standard variable in autism research, in the way that sex and cognitive ability are now. If it does not, the attempt will still have forced a clearer accounting of something the field has often treated as background: time. For now, the paper is an argument about where to look. The evidence it gathers is strong enough to justify looking.

Sources and Further Reading

  1. Johnson, M. H., Charman, T., Warrier, V., & Jones, E. J. H. (2026). Elucidating the heterogeneity in autism through developmental trajectories. Nature Mental Health. Published November 18, 2026. https://doi.org/10.1038/s44220-026-00755-w
  2. Georgiades, S., Bishop, S. L., & Frazier, T. (2017). Editorial Perspective: Longitudinal research in autism – introducing the concept of ‘chronogeneity’. Journal of Child Psychology and Psychiatry, 58(5), 634-636.
  3. Ozonoff, S., Young, G. S., Brian, J., Charman, T., Shephard, E., Solish, A., & Zwaigenbaum, L. (2018). Diagnosis of Autism Spectrum Disorder After Age 5 in Children Evaluated Longitudinally Since Infancy. Journal of the American Academy of Child and Adolescent Psychiatry, 57(11), 849-857.e2.
  4. Zhang, X., Grove, J., Gu, Y., et al. (2025). Polygenic and developmental profiles of autism differ by age at diagnosis. Nature, 646, 1146-1155.
  5. University of Cambridge (2025). Study reveals genetic and developmental differences in people with earlier versus later autism diagnosis. News release, October 1, 2025.
  6. Mandy, W., Midouhas, E., Hosozawa, M., Cable, N., Sacker, A., & Flouri, E. (2022). Mental health and social difficulties of late-diagnosed autistic children, across childhood and adolescence. Journal of Child Psychology and Psychiatry, 63(11), 1405-1414.
  7. Shaw, K. A., Williams, S., et al. (2025). Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years – Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States, 2022. MMWR Surveillance Summaries, 74(No. SS-2), 1-22.
  8. St John, T., Corrigan, N. M., Rokem, A., Estes, A. M., Hazlett, H. C., Pandey, J., et al. (2026). Longitudinal profiles of executive function in autistic and non-autistic children at high likelihood of autism. Journal of Neurodevelopmental Disorders, 18(1), 21.
  9. Executive function challenges persist into young adulthood and predict mental health outcomes in autism (2026). Journal of Child Psychology and Psychiatry. https://doi.org/10.1111/jcpp.70149

About This Publication

Executive Function News is a research and analysis publication of NBEFC®, the National Board for Executive Function Certification. NBEFC offers board certification for executive function coaches at nbefc.org. Our editorial process applies independent journalistic standards to research coverage, regardless of the topic’s relationship to NBEFC’s programs.

Scroll to Top